drug
as of 2026-07-01ALKS 9072, Low Dose
ALKS 9072, Low dose
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Alkermes, Inc.
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
NCT01895452Phase 3Completed
A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia
NCT01493726Phase 1Completed
KOLs & investigators
2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
KOL
Robert Risinger, MD
personKOL score 0
Alkermes Medical Director, MD
personKOL score —